Rheumatology Archives - Page 2 of 5

Direct healthcare resource utilization, health-related quality of life, and work productivity in patients with moderate rheumatoid arthritis: an observational study

Authors: J Galloway, J Edwards, S Bhagat, B Parker, A L Tan, J Maxwell, M Wallington, S Blanthorn-Hazell, C Bellamy & Z Cole Published: BMC Musculoskeletal Disorders, 2021 View publication Background The...

Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data

Authors: V Strand, R Shah, C Atzinger, J Zhou, J Clewell, A Ganguli, N Tundia Published: Current Medical Research and Opinion, 2019 View publication Objective Determine healthcare resource utilization (HCRU) and costs...

Results from a cross-sectional, observational study to assess inadequate pain relief in patients with knee and/or hip osteoarthritis in Mexico

Authors: R Burgos-Vargas, J Aggarwal, K D Johnson, D Ramey, F Lozano, C Macahilig, I Doshi, K Tunceli Published: Reumatologia Clinica, 2021 View publication Introduction and objectives There is limited data that...

21st century state of rheumatoid arthritis management in the UK

Authors: Ai Lyn Tan, Maya Buch, David O’Reilly, Tom Sheeran, Georgina Nock, Sarang Chitale, Paul Emery Published: Rheumatology, 2017 View publication Background The rheumatoid arthritis (RA) Treat to Target (T2T) recommendations1 defined...

A multi-centre retrospective study to describe the impact on healthcare resource use and real world effectiveness of golimumab in ankylosing spondylitis (AS) in UK clinical practice

Authors: Karl Gaffney, Lisa Dunkley, Nicola Goodson, Sean Kerrigan, David Marshall, Ognjenka Savanovic-Abel, Raj Sengupta, Christine Mackay, Eleana Tsoumani, Eilish McCann, Timothy Futter, Joseph Hickey, Catherine Bottomley Published: Value in Health, 2017...

The resource cost of switching stable rheumatology patients from an originator biologic to a biosimilar in the UK

Authors: T Barnes, E Wong, K Thakrar, F Glen, S Young-Min, K Marchbank, A Ingram Published: Value in Health, 2017 View publication Objectives Switching stable patients from branded biologics to biosimilars may...

PRO22 A real world study investigating the resource use and burden associated with Spinal Muscular Atrophy (SMA) from the perspective of patients and carers in the UK

Authors: J J Rothwell, S A Vincent, S Saberian, M Scoto, F Muntoni Published: Value in Health, 2020 View publication To describe the types of healthcare and non-healthcare resource use and burden...

A benchmarking audit of the pre-diagnosis pathway in patients with Duchenne Muscular Dystrophy

Authors: V Gowda, M Fernandez, M Prasad, AM Childs, I Hughes, S Tirupathi, C De Goede, D O’Rourke, D Parasuraman, T Willis, S Saberian, I Davidson Published: European Journal of Neurology, 2021...

A multi‐centre retrospective study to describe the real world effectiveness of Golimumab for treating Ankylosing Spondylitis (AS) in UK clinical practice

Authors: K Gaffney, L Dunkley, N Goodson, S Kerrigan, D Marshall, O Savanovic‐Abel, R Sengupta, C Mackay, E Tsoumani, C Bottomley, T Futter, J Hickey Published: Rheumatology, 2018 View publication Background Tumour...

News